Medicine is publishing a statement of concern regarding two
Medicine articles.The journal was alerted to concerns alleging improper statistical analysis in published
article “Effects of high-intensity interval and moderate-intensity continuous
aerobic exercise on diabetic obese patients with nonalcoholic fatty liver
disease”[ which
appeared in Volume 99, Issue 10 of Medicine. After investigation, it
was found that the analysis performed was inappropriate and as a result, the data must
be re-analyzed and corrected appropriately. It was also alleged that in published
article “A randomized controlled trial on the effectiveness of 8-week
high-intensity interval exercise on intrahepatic triglycerides, visceral lipids, and
health-related quality of life in diabetic obese patients with nonalcoholic fatty liver
disease”[ appearing in
Volume 98, Issue 12 of Medicine, between-group tests are reported using
the final measure. However it does not seem to be correctly calculated. It was also
determined through investigation that the ‘interaction effect’ of exercise
on primary (and subsequent outcome measures) cannot be statistically interrogated
in.[Additionally, a concern was raised regarding potential duplication of results
in[ that were reported
in[ and “Effect of
Moderate-Intensity Aerobic Exercise on Hepatic Fat Content and Visceral Lipids in
Hepatic Patients with Diabesity: A Single-Blinded Randomised Controlled
Trial”[ which appeared
in Volume 2020 of Evidence-Based Complementary and Alternative
Medicine. After investigation, it appears duplication did not occur
as[ presents an experimental
arm (MICT), although authors appear to have failed to include deviations to experimental
arms in the clinical trial registration.The original Letter to the Editor documenting the concerns has been published on our
Author Correspondence blog. Authors and their institutions have been contacted to
address the concerns, re-analyze data, and ensure all clinical trial registration
information is accurate.
Authors: Walid Kamal Abdelbasset; Sayed A Tantawy; Dalia M Kamel; Bader A Alqahtani; Gaber S Soliman Journal: Medicine (Baltimore) Date: 2019-03 Impact factor: 1.889
Authors: Walid Kamal Abdelbasset; Shereen H Elsayed; Gopal Nambi; Saud M Alrawaili; Tamer E Elnegamy; Mona A Khalil; Sayed A Tantawy; Gaber S Soliman; Ahmed A Ibrahim; Dalia M Kamel Journal: Evid Based Complement Alternat Med Date: 2020-04-11 Impact factor: 2.629
Authors: Walid Kamal Abdelbasset; Sayed A Tantawy; Dalia M Kamel; Bader A Alqahtani; Tamer E Elnegamy; Gaber S Soliman; Ahmed A Ibrahim Journal: Medicine (Baltimore) Date: 2020-03 Impact factor: 1.889